Powered by Nielsen’s Streaming Content Ratings data, ARTEY Award winners are uniquely determined by the audience. Awards are ...
Strep throat symptoms can clear in a week, but the infection may linger. Treatment with antibiotics can prevent serious complications like rheumatic fever. Untreated strep throat can lead to ...
Results from an interim analysis in the Phase 2 STARBORN-1 trial of TARA-002 in pediatric LMs patients remain on track for 4Q 2025 Expect to present interim analysis from approximately 25 six-month ...
Streptococcus pyogenes or invasive Group A Streptococcus (iGAS) is a major clinical concern around the world, since iGAS infections can quickly escalate into life-threatening conditions such as ...
Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Necrotising soft tissue ...
Presentation of interim analysis from approximately 25 six-month evaluable BCG-Unresponsive patients in the ongoing ADVANCED-2 trial expected at a medical conference in 1Q 2026 Dosing of first patient ...
A group of researchers led by The University of Osaka have identified a novel genetic mutation in Streptococcus pyogenes, a common bacterium which causes strep throat, significantly associated with ...
3 Arts Entertainment has acquired A&A Management Group, a premier sports and entertainment management firm, the company announced on Monday. The transaction unites 3 Arts’ expertise in talent ...
Protara Therapeutics will present updated safety and efficacy data from the Phase 2 ADVANCED-2 trial for TARA-002, which is a significant step in advancing their treatment for non-muscle invasive ...
NEW YORK, April 23, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results